Trial Profile

Related and Unrelated Donor Hematopoietic Stem Cell Transplant of DOCK8 Deficiency

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Antithymocyte globulin; Busulfan; Ciclosporin; Cyclophosphamide; Fludarabine; Methotrexate; Mycophenolate mofetil; Sirolimus; Tacrolimus
Indications Graft-versus-host disease
Focus Adverse reactions; Therapeutic Use

Most Recent Events

14 Sep 2021 Biomarkers information updated
26 Aug 2013 Planned number of patients changed from 10 to 30 as reported by ClinicalTrials.gov
14 Mar 2012 Lead trial investigator (Dennis D Hickstein) identified as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com